<DOC>
	<DOCNO>NCT01507584</DOCNO>
	<brief_summary>This clinical trial design investigate efficacy profile SENSIMED Triggerfish® 24-hour IOP monitoring patient glaucoma ocular hypertension , do three time monthly interval different therapeutic regimen . This trial also evaluate efficacy SENSIMED Triggerfish® detect change intraocular pressure ( IOP ) water drink test ( WDT ) investigate .</brief_summary>
	<brief_title>The Effects Water Drinking Test Intraocular Pressure</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<criteria>Subject able comply study procedure 1880 year old Subjects diagnose glaucoma , base presence repeatable visual field loss and/or glaucomatous optic neuropathy base masked review optic disc stereophotographs ocular hypotensive treatment , diagnose ocular hypertension , IOP &gt; 22 mmHg screen visit ocular hypotensive treatment . Subject consent trial Visual acuity 20/80 good Ability understand character individual consequence study For woman childbearing potential , adequate contraception Stable antihypertensive treatment regimen 4 week prior screen visit throughout study . Exclusion criterion Subjects chronic kidney failure chronic hear disease Subjects contraindications wear contact lens Severe dry eye syndrome Keratoconus corneal abnormality Conjunctival intraocular inflammation Eye surgery prior throughout study , except prior uncomplicated cataract surgery laser minimum 3 month prior screen visit . Full frame metal glass SENSIMED Triggerfish® monitor Known hypersensitivity silicone , plaster ocular anesthesia ( proparacaine ) Pregnancy lactation Simultaneous participation clinical study No patient allow participate trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>